Breast Trials

Trial No.: Novaris CLEE011O2301C “NATALEE”

Trial Name:

Phase II Study of CDK 4/6 Inhibitor, LEE01 (Riboclib), in combination with Adjuvant endocrine therapy at varying Duration for ER-positive Breast Cancer.

Trial No.: NSABP B-59

Trial Name:

A randomized, Double-Blind, Phase III Clinical Trial of Neoadjuvant Chemotherapy with Atezolizumab or Placebo in Patients with Triple-Negative Breast Cancer Followed by Adjuvant Continuation of Atezolizumab or Placebo.

Fort Wayne North Office
(260) 484-8830
11143 Parkview Plaza Drive, Suite 100
Fort Wayne, Indiana 46845

Fort Wayne South Office
(260) 436-0800
7910 West Jefferson Boulevard, Suite 108
Fort Wayne, Indiana 46804

©2019 Fort Wayne Medical Oncology and Hematology. All Rights Reserved.